Newsroom

Discover the latest press releases,
events and updates from Unizima

Stay informed

Filter
  • All
  • Event Calendar
  • News
  • Press Release
  • Video

Advanced Therapies, 24-25th May 2022

Event Calendar

Unizima is attending the Advanced Therapies event in London. The summit will take place in May 24th and 25th and its objective is to unite advanced therapies players across the world, to give insight and to promote collaboration to accelerate the development & commercialisation of ...

Read more

Global Bioprocessing Summit, 11-13th May 2022

Event Calendar
May. This event brings together leading bioprocessing experts to share day-to-day challenges and practical solutions for the development, manufacturing and quality of cell lines, antibodies, vaccines and cell & gene therapies.
Read more

Pharma Partnering Summit, 12-13th May 2022

Event Calendar
Unizima is attending the Pharma Partnering Summit in Brussels. The summit will take place in May 12th and 13th. The Unizima team is looking forward to learn from the different speakers and to meet you.
Read more

Biotechgate Digital Partnering, 9-13 May 2022

Event Calendar

Unizima will be attending the Biotechgate Digital Partnering in May 9th to 13th. Biotechgate Digital Partnering is designed to support the business development & licensing of Pharma, Biotech, Medtech and Digital Health companies. Come and meet us on this five days of virtual ...

Read more

BIO-Europe Spring, 28-31 March 2022

Event Calendar
Unizima will be attending the BIO-Europe Spring 2022 digitally. We are looking forward to connect with you.
Read more

Bioprocessing Summit Europe, 22-24 March 2022

Event Calendar
Unizima will be attending the 5th Annual Bioprocessing summit Europe in Barcelona, Spain. Our goal is to get a broad overview of the biopharma/biotech industry's state-of-the-art technological and scientific advances covering different streams and Gene & Cell therapy manufacturing.
Read more

Univercells and Unizima announce Hala Audi as ...

Press Release

Univercells S.A. (“Univercells”) and Unizima S.A. (“the Company”), announce today the appointment of Hala Audi as Chief Executive Officer of Unizima, a Univercells Company dedicated to delivering facilities, services and expertise to meet local demand for biologics in ...

Read more

Project MADIBA – Groundbreaking partnership ...

Press Release

An innovative new partnership was announced today to revolutionize access to COVID-19 and other vaccines in Africa by manufacturing these vaccines at the Institut Pasteur de Dakar (IPD) as part of the project known as MADIBA, “Vaccines in Africa, for Africa”

Read more

Africa Women’s Health: The Role Of The Private ...

Event Calendar
The Africa Health Business Symposium (AHBS) is a pan-African conference that sits at the heart of the African healthcare scene. Via AHBS, AHB has set the pace towards constructive working relationships between the public and private sector, creating a more enabling environment for the ...
Read more

Testimonials

Laura – 28 years old

Colombia – Patient diagnosted with rheumatoid arthritis.
October 2020

Hello, my name is Laura, I am 28 years old. I am from Colombia and I have been diagnosed with rheumatoid arthritis ten years ago.
In addition to being a patient, I am also a doctor and in the past ten years I have undergone multiple treatments during which on two occasions I have had the opportunity to be treated with biotechnological or biological drugs. These have been the only two occasions during which I have been able to go into total remission of my disease and its symptoms.

Dr Claudio Galarza

Ecuador – Rheumatologist.
March 2021

Hello everyone. I am Claudio Galarza, I am a rheumatologist. 

For the past 20 years I have been treating patients who suffer from autoimmune and rheumatic diseases with biological therapy. This therapy has allowed to achieve minimal disease activity and even remission in most cases.

Get in touch

Unizima is offering the following integrated project delivery method as part of a unique value proposition for its customers, allowing them to lean on a preferred intermediary, offering a turnkey solution.